FDA Classifies Continuous Glucose Monitor Data Management System as Class I Device

Summary

The US Food and Drug Administration (FDA) has classified the continuous glucose monitor data management system into Class I, a category that provides general controls, aiming to ensure the device's safety and effectiveness while reducing regulatory burdens and increasing access to innovative devices for patients.